Conference Calendar

October 28-29 - Musculoskeletal New Ventures Conference

November 5-8 - American Academy of Implant Dentistry

Complete Calendar »

Earnings Calendar

Oct 29 @ 8:30 AM ET - Dentsply International

Oct 29 @ 5:00 PM ET - K2M Group Holdings, Inc

Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

MacroporeBiosurgery

Musculosketal News Roundup 25-Oct-07 BY LAUREN UZDIENSKI, OCTOBER 25, 2007

Earnings ArthroCare Corp. reported 3Q:07 total revenues of $78.5 million, an increase of 21% over the comparable quarter. Revenues missed estimates by $0.11 million. The company reported net income of $11.1 million, or $0.39 per share, up 28% over 3Q:06... more

Orthopedic News Roundup 7-June-07 BY LAUREN UZDIENSKI, JUNE 7, 2007

M&A The private equity consortium set to acquire Biomet increased its buyout offer to $46.00 per share in cash, or an equity value of $11.4 billion. The new offer represents a 32.3% premium over the April 2006 common stock closing... more

Wright Medical, Regeneration Technologies, LifeCell, Orthovita, MacroPore and Stellar International Slated to Join 30 Other Presenters at October Biomaterials Summit in New York BY ROBIN R. YOUNG CFA, AUGUST 23, 2004

Headlining this year's one-day Biomaterials Summit will be Wright Medical, Regeneration Technologies, LifeCell, Orthovita, MacroPore and Stellar International. All are leaders in the field and working on significant new technologies. Wright Medical, whose sales for the first half of 2004... more

First Resorbable (Non-Allograft) Interbody Implant Introduced in Europe BY ROBIN R. YOUNG CFA, JULY 12, 2004

Macropore Biosurgery, Inc. (Frankfurt: XMP) announced last week that the European regulatory agency had approved it s HYDROSORB' Boomerang' spine fusion implants. (By the way, who names these products? Boomerang?) Made from Polylactic Acid, the material resorbs in the body... more

Fat Derived Stem Cells Reach Important Milestones to Commercialization for bone, cartilage and muscle repair BY ROBIN R. YOUNG CFA, APRIL 19, 2004

In two separate studies, stem cells derived from the patient's own fat tissue, otherwise known as adipose derived stem cells, were shown to adapt and grow into either bone tissue or heart muscle tissue, without requiring any external growth factors... more

Macropore Posts 140% Revenue Jump on Sales of Resorbable Polymers for Spine, Trauma and Carniomaxillofacial; Losses Continue, Though Reduced BY ROBIN R. YOUNG CFA, APRIL 19, 2004

Macropore, the San Diego based biomaterials company whose stock trades on the Frankfurt exchange (go figure), posted exceptional revenue growth for the December quarter. (They're a little behind on their announcements. March quarter numbers due in June?) Sales for the... more


Complete Archive